Y-mAbs Therapeutics
YMAB
YMAB
94 hedge funds and large institutions have $140M invested in Y-mAbs Therapeutics in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 37 increasing their positions, 32 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
-4
Holders Change %
-4.08%
% of All Funds
1.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
11
Increased
37
Reduced
32
Closed
14
Calls
$17K
Puts
$16K
Net Calls
+$1K
Net Calls Change
-$15K
Top Buyers
| 1 |
CP
1
Caligan Partners
New York
|
$7.15M |
| 2 |
BFM
2
Boothbay Fund Management
New York
|
$4.73M |
| 3 |
3
BlackRock
New York
|
$19.9M |
| 4 |
4
Morgan Stanley
New York
|
$3.34M |
| 5 |
CCIA
5
Campbell & Co Investment Adviser
Baltimore,
Maryland
|
$562K |
